“dana-farber-cancer-institute” Archives

in
Entry Author Date Location
In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions 05/31/17 National
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
Last Chance to Snag a Ticket for What’s Hot in Boston Biotech 05/10/17 Boston
Grab Your Ticket for What’s Hot in Boston Biotech on May 11th 05/03/17 Boston
Cellular Dynamics Adds to Stem Cell Work With Harvard Institute 04/25/17 Wisconsin
Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today 04/06/17 Boston
Veering Off Topic With General Catalyst’s Larry Bohn 03/10/17 Boston
Acetylon Crafts New Buyout Deal With Celgene, Spins Out Startup Regenacy 12/02/16 Boston
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
Amid Leadership Changes, NY Biotech Braces For its “Pivotal Moment” 05/12/16 New York
Making the Price Right: Ideas To Change Drug Costs Gain Momentum 04/05/16 National
Celldex’s Brain Cancer Vaccine Fails Key Phase 3 Test, Shares Fall 03/07/16 Boston
East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More 03/03/16 Boston
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Tech Mogul, Patriots Owner Lavish $73M On Dana-Farber Startup 01/07/16 Boston
With $48M For Petra Pharma, Accelerator Places First NYC Bet 01/06/16 New York
With SQZ Deal, Roche Finally Dips Its Toes into Cell Therapy 12/07/15 Boston
With $55M, Neon Wants To Make the Cancer Vaccine “Problem” Personal 10/01/15 Boston
MD Anderson’s Chin Heads to UT to Lead Efforts to Fight Diabetes 04/02/15 Texas
Texas Cancer Center Seeks to Speed Discovery with Applied Research 12/03/14 Texas
Syros Raises $53M More To Push Gene-Control Drugs Into Human Trials 10/27/14 Boston
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim 02/18/14 Boston
Red Sox Nutritionist on Sports, Stress, & Segterra (and World Series) 10/28/13 Boston
Celgene Nabs Option to Buy Acetylon for More Than $1.7B 07/29/13 Boston
Big Data Is BS in Healthcare. When Will It Become Real? 04/15/13 National
East Coast Biotech Roundup: Bristol-Myers, Syros, On-Q-ity, Ziopharm 04/12/13 Boston
Page 1 of 3 next page »